GABA Promoter and PDE4 Inhibitor in the Management of Polycystic Ovary Syndrome: A Nutraceutical Approach.

Dietary modulation of inflammatory and neuroendocrine pathways represents a promising complementary approach to PCOS therapy. Further clinical research is needed to validate efficacy, optimize formulations, and ensure the safety of such integrative treatments.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-02-25
DOI
https://doi.org/10.2174/0115701638396146251115115703
Primary Topic
Ovarian function and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GABA Promoter and PDE4 Inhibitor in the Management of Polycystic Ovary Syndrome: A Nutraceutical Approach.

Lucy Mohapatra, Ankita Wal, Divyanshi Gupta
PubMed
Ovarian function and disorders
article

GABA Promoter and PDE4 Inhibitor in the Management of Polycystic Ovary Syndrome: A Nutraceutical Approach.

Lucy Mohapatra, Ankita Wal, Divyanshi Gupta
article en

Abstract

Dietary modulation of inflammatory and neuroendocrine pathways represents a promising complementary approach to PCOS therapy. Further clinical research is needed to validate efficacy, optimize formulations, and ensure the safety of such integrative treatments.

PubMed
Pushpawati Singhania Research Institute (IN), Amity University (AE)
Openalex Percentile: Top 34%
Ovarian function and disorders
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.